Literature DB >> 15655399

Motion sickness.

John F Golding1, Michael A Gresty.   

Abstract

PURPOSE OF REVIEW: The public's longstanding resigned tolerance to motion sickness threatens to change, due to the widespread introduction of nauseogenic tilting trains and the increasing use of virtual reality immersion. RECENT
FINDINGS: Scientific effort over the last 5 years has focused on precise evaluation of the stimuli that provoke sickness and on the development of behavioural and new pharmacological interventions to suppress sickness.
SUMMARY: The precise mechanical ride characteristics of vehicles that provoke sickness have been identified and this will lead to guidelines for future engineering design, especially for suspension systems that compensate for inertial tilt, and recommendations for passengers at risk. The frequency characteristics of motion provoking sickness have been defined with greater precision and identified with shifts in perception of motion versus orientation, and changes in the quality of reflex eye movements. Ability to modify readily the time constant of vestibular 'velocity store' has emerged as a potential candidate marker of successful motion sickness habituation. Behavioural 'autogenic' countermeasures to the development of sickness, such as controlled breathing, which can be implemented readily, are shown to have significant ameliorating effects on nausea and are of value for short term moderate exposures. New classes of pharmacological agents such as N-methyl-D-aspartate antagonists and 5HT1a receptor agonists show promise in animals but await trials in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655399     DOI: 10.1097/00019052-200502000-00007

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  14 in total

1.  mu-Opiate receptor agonists -- a new pharmacological approach to prevent motion sickness?

Authors:  Bärbel Otto; Rudolf L Riepl; Carsten Otto; Joachim Klose; Paul Enck; Sibylle Klosterhalfen
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

Review 2.  The Neurophysiology and Treatment of Motion Sickness.

Authors:  Andreas Koch; Ingolf Cascorbi; Martin Westhofen; Manuel Dafotakis; Sebastian Klapa; Johann Peter Kuhtz-Buschbeck
Journal:  Dtsch Arztebl Int       Date:  2018-10-12       Impact factor: 5.594

3.  Motion sickness on tilting trains.

Authors:  Bernard Cohen; Mingjia Dai; Dmitri Ogorodnikov; Jean Laurens; Theodore Raphan; Philippe Müller; Alexiou Athanasios; Jürgen Edmaier; Thomas Grossenbacher; Klaus Stadtmüller; Ueli Brugger; Gerald Hauser; Dominik Straumann
Journal:  FASEB J       Date:  2011-07-25       Impact factor: 5.191

4.  Visually induced motion sickness can be alleviated by pleasant odors.

Authors:  Behrang Keshavarz; Daniela Stelzmann; Aurore Paillard; Heiko Hecht
Journal:  Exp Brain Res       Date:  2015-01-30       Impact factor: 1.972

Review 5.  The role of oesophageal physiological testing in the assessment of noncardiac chest pain.

Authors:  Henriette Heinrich; Rami Sweis
Journal:  Ther Adv Chronic Dis       Date:  2018-09-11       Impact factor: 5.091

6.  Scopolamine patch withdrawal syndrome.

Authors:  Steve H Lau; Chris Vaneaton
Journal:  Hosp Pharm       Date:  2014-03

Review 7.  Vestibulo-sympathetic responses.

Authors:  Bill J Yates; Philip S Bolton; Vaughan G Macefield
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 8.  Opportunities for the replacement of animals in the study of nausea and vomiting.

Authors:  A M Holmes; J A Rudd; F D Tattersall; Q Aziz; P L R Andrews
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

Review 9.  Integration of vestibular and emetic gastrointestinal signals that produce nausea and vomiting: potential contributions to motion sickness.

Authors:  Bill J Yates; Michael F Catanzaro; Daniel J Miller; Andrew A McCall
Journal:  Exp Brain Res       Date:  2014-04-16       Impact factor: 1.972

10.  Gaze During Locomotion in Virtual Reality and the Real World.

Authors:  Jan Drewes; Sascha Feder; Wolfgang Einhäuser
Journal:  Front Neurosci       Date:  2021-05-24       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.